DocGo Inc
NASDAQ:DCGO
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2.84
6.17
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one DCGO stock under the Base Case scenario is 4.1 USD. Compared to the current market price of 4.38 USD, DocGo Inc is Overvalued by 6%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
DocGo Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for DCGO cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
DocGo Inc
Balance Sheet Decomposition
DocGo Inc
Current Assets | 328.3m |
Cash & Short-Term Investments | 89.5m |
Receivables | 233.7m |
Other Current Assets | 5.2m |
Non-Current Assets | 165.6m |
Long-Term Investments | 634.1k |
PP&E | 42.4m |
Intangibles | 82.9m |
Other Non-Current Assets | 39.7m |
Current Liabilities | 150.2m |
Accounts Payable | 35.1m |
Accrued Liabilities | 62.7m |
Short-Term Debt | 30m |
Other Current Liabilities | 22.4m |
Non-Current Liabilities | 18.4m |
Long-Term Debt | 9.6m |
Other Non-Current Liabilities | 8.9m |
Earnings Waterfall
DocGo Inc
Revenue
|
695m
USD
|
Cost of Revenue
|
-455.2m
USD
|
Gross Profit
|
239.8m
USD
|
Operating Expenses
|
-191.9m
USD
|
Operating Income
|
47.8m
USD
|
Other Expenses
|
-17m
USD
|
Net Income
|
30.8m
USD
|
Free Cash Flow Analysis
DocGo Inc
USD | |
Free Cash Flow | USD |
DCGO Profitability Score
Profitability Due Diligence
DocGo Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Score
DocGo Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
DCGO Solvency Score
Solvency Due Diligence
DocGo Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
DocGo Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DCGO Price Targets Summary
DocGo Inc
According to Wall Street analysts, the average 1-year price target for DCGO is 6.34 USD with a low forecast of 5.05 USD and a high forecast of 8.4 USD.
Dividends
Current shareholder yield for DCGO is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
DCGO Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
DocGo, Inc. operates as an emerging growth company, which provides mobile health services. The company is headquartered in New York City, New York. The company went IPO on 2020-10-15. The firm uses dispatch and communication technology to provide healthcare transportation and mobile services in-person medical treatment directly to patients in their homes, workplaces and other non-traditional locations, in various metropolitan cities in the United States and the United Kingdom. The company operates through two segments: medical mobility solutions and mobile health solutions. The Company’s medical mobility solutions are offered under the Ambulnz brand. The company enables access to local clinical services, including primary and specialty care, dialysis treatments for chronic care management, and transfers between clinical settings. The Company’s mobile health solutions include services performed at home and offices, coronavirus disease (COVID-19) testing, and event services, which include on-site healthcare support at sporting events and concerts.
Contact
IPO
Employees
Officers
The intrinsic value of one DCGO stock under the Base Case scenario is 4.1 USD.
Compared to the current market price of 4.38 USD, DocGo Inc is Overvalued by 6%.